Ready-to-Administer
R.E.C.K.
For Periarticular Injection
Each 100 ml total dose of Quva’s patented, compounded formulation contains:
- 123 mg (2.46mg/mL) Ropivacaine HCl
- 0.25 mg (0.005mg/mL) Epinephrine
- 0.04 mg (0.0008mg/mL) Clonidine HCl
- 15 mg (0.3mg/mL) Ketorolac Tromethamine
These ingredients are combined in a solution of sodium chloride to provide a total volume of 50 mL per ready-to-administer syringe. 100 mL total dose2 is achieved with two 50 ml syringes. It should be stored at room temperature, and protected from light.
Act now for a low cost, OPIOID-FREE sterile solution for periarticular injection!
PRODUCT #
PRODUCT DESCRIPTION
PRODUCT SOURCE
BUD
(DAYS)
(DAYS)
CASE
QUANTITY
QUANTITY
70092143350
R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride Solution, 50 ml fill, 50 ml Syringe
API to Sterile
90
5
Benefits of the R.E.C.K injection include:
The ready-to-administer syringe makes it easy for the operating room team to decant from the syringe and draw up into the surgeon's preferred syringe and needle combination. Other benefits include::- Supports local infiltration anesthesia which is a mainstay of multimodal pain management
- Eliminates the need to compound in the hospital or mix products in the O.R.
- 90-day beyond use date helps reduce waste
- Supplied by an FDA registered 503B outsourcing facility
- Shipped directly to your hospital pharmacy and available in all 50 states
How to use R.E.C.K
R.E.C.K solution is a sterile solution and comes in a pre-filled, ready-to-administer container to save time and reduce waste. OR team members can simply decant the product into a sterile container and draw it up into their preferred combination of syringe and needle. They can then administer R.E.C.K as a periarticular injection.
An injection of ropivacaine, epinephrine, clonidine and ketorolac (R.E.C.K) is used as part of a multimodal pain regimen as a way to minimize postoperative pain and support patients’ recovery from their surgery. Poor pain management can increase the cost of care, lead to lengthier hospital stays, reduce functional outcomes, result in chronic pain syndromes, side effects from chronic analgesic and opioid use. Below, you can download The Journal of Arthroplasty prospective, a randomized, double-blind study for the appropriate use of R.E.C.K.